Collaboration
AstraZeneca and Daiichi Sankyo Enter Collaboration to Develop and Commercialize New Antibody Drug Conjugate
AstraZeneca
PR-M07-20-NI-41Jul 27, 2020
Vaccine Manufacturing
Daiichi Sankyo Announces Start of Discussions with AstraZeneca Regarding Supply in Japan of Novel Coronavirus Vaccine
Daiichi-Sankyo
PR-M06-20-NI-036-1473Jun 26, 2020
FDA Review
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Daiichi-Sankyo
PR-M06-19-NI-045Jun 26, 2019
Oncology
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA®▼ (edoxaban)
Daiichi-Sankyo
PR-M09-18-NI-018Sep 07, 2018
Research
Daiichi Sankyo and DarwinHealth Enter Exclusive Research Collaboration for Novel Cancer Target Initiative
Daiichi-Sankyo
PR-M04-18-NI-028Apr 09, 2018